-
Article | 2020.07.27
The Institut Pasteur is a private, non-profit foundation
The Institut Pasteur is ideally placed to successfully pursue its primary missions of research, public health, education and the identification of research applications. Its many strengths include the outstanding quality of its staff, the excellence of its research and infrastructures, and the critical mass of the Institut Pasteur International Network.The Technology Transfer and Industrial...
-
Article | 2020.08.20
R&D collaborations
The combination of our scientific expertise and industrial awareness will enable you to identify innovative solutions to meet your challenges.
-
News | 2020.10.05
New Free On-Line Course Created By Institut Pasteur: Clinical Trials In Infectious And TropicalL Diseases
While clinical research has developed for many years in high income countries, it is becoming increasingly important in countries with limited resources. Indeed, beyond common pathologies, specific pathologies such as infectious and tropical diseases make it necessary to conduct trials adapted to the context of countries with limited resources. In addition, re-evaluations of therapeutic or...
-
News | 2020.10.05
New Edition Of The Free On-Line Mooc Malaria
Malaria remains a major public health problem in many low and middle-income countries in the tropics. In 2018, WHO estimates that there were around 228 million cases of malaria that caused 405,000 deaths, primarily in sub-Saharan Africa. While the intensive application of currently available malaria control tools has greatly reduced malaria transmission in many parts of the world where malaria is...
-
News | 2020.10.12
A feedback on 10 months of mobilization of the Institut Pasteur against covid-19
On Thursday, October 8, 2020, the Institut Pasteur in Paris organized an exceptional digital conference to review 10 months of mobilization against Covid-19, a force still in action for global health. Four experts from the Institut Pasteur were present to talk about the epidemic, tests, treatments, vaccines, scientific modelling, and answer questions from Internet users. This conference is...
-
News | 2020.11.02
New Edition Of The Free On-Line Mooc Tuberculosis
Tuberculosis (TB) remains one of the ten leading causes of death worldwide and the biggest killer among infectious diseases, surpassing even AIDS and malaria. Although it is hoped that TB can be eliminated within the next couple of decades, the incidence is currently falling by only 1.5% per year. Each year there are about 10 million new cases of TB and a half a million of these are multi-drug...
-
News | 2021.11.10
COVID-19: Kamala Harris, Vice President of the United States, salutes the Institut Pasteur's response in tackling the pandemic
As part of her trip to France for the fourth Paris Peace Forum – which includes three round tables on the challenges raised by the COVID-19 pandemic –, Kamala Harris, Vice President of the United States, visited the Institut Pasteur on November 9, 2021. She met several of the Institut Pasteur's scientists and saluted the unprecedented response of the Institut Pasteur's scientific community in...
-
Fiche maladie | 2021.07.07
Buruli Ulcer
Buruli ulcer is a disease caused by a bacterium that multiplies in skin and is currently reported in 33 countries, mostly in tropical regions. Although not fatal, it can lead to permanent disabilities, imposing a heavy burden on both patients and society.
-
Document de presse | 2005.04.18
Newborn susceptibility to infection now deciphered
A joint Institut Pasteur-Inserm team has deciphered key mechanisms in the development of newborn immune systems. This study has made it possible to understand why infants are susceptible to early infections that cause high mortality rates, particularly in developing countries. Understanding these mechanisms offers possibilities for new types of treatment and vaccines adapted to protect newborns...
-
News | 2016.12.01
Hepatitis B may infect twice more African babies than HIV
The number of newborns infected with Hepatitis B may be twice as high as HIV in sub-Saharan Africa.While the risk of mother-to-child transmission of Hepatitis B is well documented in Asia, data regarding the situation in Africa are still scarce. In an article published in the Alimentary Pharmacology & Therapeutics journal, Epidemiologists from Institut Pasteur, Ecole Pasteur/CNAM de Santé...